$NTSK

Lightspeed Venture Partners IX, L.P. sold $2.8M of NTSK (indirect holdings)

Lightspeed Venture Partners IX, L.P. sold 229,696 indirectly-held shares of Netskope Inc (NTSK) at an average of $12.21 ($11.70–$12.23, $2.80M total) across 2 trades over 2026-07-08 to 2026-07-09.

Original reporting
SEC EDGAR · Lightspeed Venture Partners IX, L.P.
Published Jul 10, 2026, 12:11 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 10, 2026, 12:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NTSK
Neutral
medium confidence
Mentioned
$NTSK
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NTSKNeutralLow
01

Why it matters

Traders may monitor for follow-on selling pressure or interpret the transaction as sentiment, but there is no accompanying operational or financial update in the text.

02

Market read

A disclosed, sizable open-market sale by a 10% owner at $11.70 to $12.23, with the position fully exited, may slightly influence sentiment but lacks fundamental triggers.

03

What to watch

The filing does not state the fund’s rationale, tax considerations, or whether other holdings exist at the same beneficial owner level beyond the reported indirect position.

Relevance 6/10Novelty 4/10Timing: filed after-hours on 2026-07-09, covering sales from 2026-07-08 to 2026-07-09

Background

The article is an SEC Form 4 insider transaction disclosure for Netskope, reported by a 10% owner via indirect holdings.

Company-level read

Ticker impact

$NTSKNeutralMedium confidence
Context

Netskope (NTSK) disclosed via Form 4 that Lightspeed Venture Partners IX, L.P. sold 229,696 shares in open-market transactions at $11.70 to $12.23.

Expected impact

Near-term impact is likely limited, though it can add mild overhang sentiment if traders interpret it as reduced insider conviction.

Evidence & confidence

Form 4 provides a concrete datapoint (size, price range, and post-sale holdings), but the article lacks any accompanying fundamental catalyst or guidance change.

Market effects

Limited read-across to the broader cybersecurity software group because this is a single-issuer insider sale without sector-wide news.

No clear regional market linkage from the filing details provided.

Minimal global relevance; the disclosure is company-specific and does not indicate a broader transaction or regulatory action.

Counterpoint

The sale could be routine liquidity management by a fund, and the absence of a 10b5-1 plan does not necessarily imply negative fundamentals.

Key entities

  • Netskope Inc

    Subject of the Form 4 disclosure; shares sold by a 10% owner via indirect holdings.

  • Lightspeed Venture Partners IX, L.P.

    Reporter of the Form 4 transaction; sold 229,696 shares and reported 0 shares remaining.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NTSKMed

Why Netskope Stock Crushed it This Week

Netskope (NTSK) shares rose 19% this week, benefiting from improved cybersecurity sentiment and a buy rating from Stephens with a $21 price target. The surge followed AI safety concerns raised by industry leaders, driving demand for cybersecurity stocks.

$NTSKHighAI 8/10

Netskope’s (NTSK) AI Security Push Is Already Paying Off

Netskope (NTSK) reported Q2 revenue of $220.5M, up 27% YoY, and raised its full-year outlook. AI security initiatives are driving growth, with 33% of its pipeline in or entering the proof-of-concept phase. However, the company posted negative free cash flow of $29.8M and expects a full-year free cash flow margin of about 2%.

$NTSKHighAI 8/10

Netskope (NTSK) Q2 2027 Earnings Call Transcript

Netskope (NTSK) reported Q2 2027 earnings with ARR of $899M (27% growth), revenue of $220.5M (29% growth), and raised full-year revenue guidance to $888M-$892M. Key metrics include 114% net retention rate, 1,686 large customers, and 59% platform adoption. Management highlighted AI security opportunities and risks, including faster transition to annual billings.

$NTSKMedAI 8/10

Netskope (NTSK) Stock Rises As ARR Growth Outruns Profit Progress

Netskope (NTSK) stock rose 4.3% to $14.34 after reporting Q2 2027 revenue of $220.5m (up 29% YoY) and ARR of $899m (up 27% YoY). Net loss widened 23% to $110.8m, but adjusted operating margin improved to a 9% loss. Management targets positive free cash flow in Q3. Analysts debate whether growth justifies valuation.

$NTSKMed

BMO raises Netskope stock price target on ARR growth outlook

BMO Capital increased its price target for Netskope (NTSK) to $18.00 from $13.00, citing strong ARR growth and improved performance. The stock, trading at $14.29, has a 26% upside potential. Netskope reported Q2 earnings beating estimates, with revenue of $221M and raised its full-year outlook. Multiple analysts raised their price targets following the results.